United Therapeutics Corporation Debt Securities, Held-to-Maturity, Fair Value, Maturity, Allocated and Single Maturity Date, Year One
United Therapeutics Corporation (UTHR) had Debt Securities, Held-to-Maturity, Fair Value, Maturity, Allocated and Single Maturity Date, Year One of $37.40 million as of 2018-12-31, per its 10-K filed 2019-02-27.
Discontinued › Notes › Investments › Debt and Equity Securities › Debt Securities, Held-to-Maturity, Maturity
us-gaap:HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue · last filed 2019-02-27
- 2018-12-31: Debt Securities, Held-to-Maturity, Fair Value, Maturity, Allocated and Single Maturity Date, Year One $37.40M.
- 2017-12-31: Debt Securities, Held-to-Maturity, Fair Value, Maturity, Allocated and Single Maturity Date, Year One $27.70M.
- 2016-12-31: Debt Securities, Held-to-Maturity, Fair Value, Maturity, Allocated and Single Maturity Date, Year One $27.80M.
- 2016-09-30: Debt Securities, Held-to-Maturity, Fair Value, Maturity, Allocated and Single Maturity Date, Year One $79.60M.
| Period end | Debt Securities, Held-to-Maturity, Fair Value, Maturity, Allocated and Single Maturity Date, Year One |
|---|---|
| 2018-12-31 | $37.40M 10-K · filed 2019-02-27 |
| 2017-12-31 | $27.70M 10-K · filed 2018-02-21 |
| 2016-12-31 | $27.80M 10-K · filed 2017-02-22 |
| 2016-09-30 | $79.60M 10-Q · filed 2016-10-27 |
| 2016-06-30 | $107.30M 10-Q · filed 2016-07-28 |
| 2016-03-31 | $128.40M 10-Q · filed 2016-04-28 |
| 2015-12-31 | $121.93M 10-K · filed 2016-02-25 |
| 2015-09-30 | $156.77M 10-Q · filed 2015-10-27 |
| 2015-06-30 | $185.92M 10-Q · filed 2015-07-28 |
| 2015-03-31 | $230.55M 10-Q · filed 2015-04-28 |
| 2014-12-31 | $297.97M 10-K · filed 2015-02-24 |
| 2014-09-30 | $270.69M 10-Q · filed 2014-10-28 |
| 2014-06-30 | $308.79M 10-Q · filed 2014-07-29 |
| 2014-03-31 | $346.87M 10-Q · filed 2014-04-29 |
| 2013-12-31 | $409.75M 10-K · filed 2014-02-25 |
| 2013-09-30 | $394.86M 10-Q · filed 2013-10-29 |
| 2013-06-30 | $353.21M 10-Q · filed 2013-07-25 |
| 2013-03-31 | $408.84M 10-Q · filed 2013-04-25 |
| 2012-12-31 | $325.39M 10-K · filed 2013-02-26 |
| 2012-09-30 | $240.34M 10-Q · filed 2012-11-01 |
| 2012-06-30 | $235.49M 10-Q · filed 2012-07-26 |
| 2012-03-31 | $252.39M 10-Q · filed 2012-04-26 |
| 2011-12-31 | $240.88M 10-K · filed 2012-02-28 |
| 2011-09-30 | $350.63M 10-Q · filed 2011-10-27 |
| 2011-06-30 | $409.28M 10-Q · filed 2011-07-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |